Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$572K Buy
3,900
+20
+0.5% +$3.63K 0.03% 75
2026
Q1
$571K Sell
3,880
-326
-8% -$53K 0.03% 71
2025
Q4
$820K Buy
4,206
+180
+4% +$42.9K 0.05% 66
2025
Q3
$1.13M Hold
4,026
0.07% 58
2025
Q2
$880K Sell
4,026
-259
-6% -$41.8K 0.06% 63
2025
Q1
$599K Buy
4,285
+235
+6% +$38.3K 0.04% 67
2024
Q4
$675K Sell
4,050
-5
-0.1% -$888 0.05% 62
2024
Q3
$691K Hold
4,055
0.05% 60
2024
Q2
$573K Hold
4,055
0.05% 62
2024
Q1
$509K Buy
4,055
+5
+0.1% +$572 0.04% 65
2023
Q4
$427K Buy
+4,050
New +$442K 0.04% 65

Other funds holding ORCL

Rebalance's ORCL Position: Q2 2026 in Review

Rebalance increased its Oracle (ORCL) stake by 0.52% in Q2 2026, buying an estimated $3.63K and bringing the position to 3,900 shares worth $572K. The position accounts for 0.03% of the portfolio, ranked #75.

Rebalance first reported a position in ORCL in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.13M in Q3 2025. 1,681 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Rebalance held 3,900 shares of Oracle worth $572K as of Q2 2026.
  • Rebalance bought 20 Oracle shares in Q2 2026, an estimated $3.63K.
  • Oracle made up 0.03% of Rebalance's portfolio in Q2 2026, its #75 holding.
  • Rebalance first reported a position in Oracle in Q4 2023 and has held it in 11 quarters since.
  • Rebalance's Oracle position peaked at $1.13M in Q3 2025.
  • 1,681 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Rebalance's 13F filing for Q2 2026, filed 16 Jul 2026.